Clinical effect of Clostridium Butyricum Powder combined with human immunoglobulin in the treatment of children with severe hand，foot and mouth disease
YUE Jia1 LIANG Xue2 LIU Jingwei2 PIAO Jinhua3
1.Pediatric Clinic, the First Hospital of Jilin University, Jilin Province, Changchun 130000, China;
2.Children ICU, the First Hospital of Jilin University, Jilin Province, Changchun 130000, China;
3.Department of Children Cardiovascular, the First Hospital of Jilin University, Jilin Province, Changchun 130000, China
Abstract：Objective To investigate the clinical effect of Clostridium Butyricum Powder combined with human immunoglobulin in the treatment of children with severe hand, foot and mouth disease (HFMD). Methods A total of 123 children with severe HFMD admitted to the First Hospital of Jilin University from November 2014 to November 2018 were selected, they were divided into control group (n = 61) and research group (n = 62) according to the random number table method. Children in the control group were treated with human immunoglobulin, while children in the research group were treated with Clostridium Butyricum Powder combined with human immunoglobulin. The clinical efficacy, immune function and intestinal barrier of the two groups were compared. The adverse reactions of children in the two groups during the treatment were recorded. Results The total effective rate of the study group was higher than the control group after 5 days of treatment (P < 0.05). Immunoglobulin (Ig) A and IgG in the study group were higher than those in the control group (P < 0.05), and IgM was lower than that in the control group (P < 0.05). After 5 days of treatment, diamine oxidase, D-lactic acid and endotoxin in the two groups were lower than before treatment, and those in the study group were lower than the control group (P < 0.05). There was no statistically difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion Clostridium Butyricum Powder combined with human immunoglobulin is effective in the treatment of severe HFMD children. It can effectively improve the immune function and intestinal barrier function of children, it has certain clinical application value.
岳佳1 梁雪2 刘景伟2 朴金花3. 酪酸梭菌活菌散联合人免疫球蛋白治疗重症手足口病患儿的临床效果[J]. 中国医药导报, 2019, 16(27): 97-100.
YUE Jia1 LIANG Xue2 LIU Jingwei2 PIAO Jinhua3. Clinical effect of Clostridium Butyricum Powder combined with human immunoglobulin in the treatment of children with severe hand，foot and mouth disease. 中国医药导报, 2019, 16(27): 97-100.
[1] Chen YF，Hu L，Xu F，et al. A case report of a teenager with severe hand，foot，and mouth disease with brainstem encephalitis caused by enterovirus 71 [J]. BMC Pediatr，2019，19（1）：59.
[2] 朱磊，胡丹，张晓文，等.丹参注射液联合西医常规疗法治疗重症手足口病的临床研究[J].国际中医中药杂志，2015，37（９）：796-799.
[3] Zhang D，Chen J，Ba-Thein W. Hand-foot-mouth disease and use of steroids，intravenous immunoglobulin，and traditional Chinese herbs in a tertiary hospital in Shantou，China [J]. BMC Complement Altern Med，2018，18（1）：190.
[4] 王强.醒脾养儿颗粒联合酪酸梭菌活菌散治疗小儿消化不良性腹泻的研究[J].现代中西医结合杂志，2015，24（２）：170-172.
[5] 中华人民共和国卫生部.手足口病诊疗指南（2010年版）[J].国际呼吸杂志，2010，30（24）：1473-1475.
[6] Zou JJ，Jiang GF，Xie XX，et al. Application of a combined model with seasonal autoregressive integrated moving average and support vector regression in forecasting hand-foot-mouth disease incidence in Wuhan，China [J]. Medicine （Baltimore），2019，98（6）：e14195.
[7] 熊颖.手足口病病毒抗体喷剂对小儿手足口病的疗效[J].广东医学，2017，38（1）：259-260.
[8] Ji H，Fan H，Lu PX，et al. Surveillance for severe hand，foot，and mouth disease from 2009 to 2015 in Jiangsu province：epidemiology，etiology，and disease burden [J]. BMC Infect Dis，2019，19（1）：79.
[9] 陈贤玉，王昆华.肠黏膜生物屏障的研究现状和进展[J].结直肠肛门外科，2012，18（4）：268-272.
[10] 李妍.酪酸梭菌活菌散辅助治疗新生儿病理性黄疸的效果[J].中国医药导报，2018，15（18）：88-91.
[11] 殷景远，单红艳，李亚岭，等.酪酸梭菌活菌散联合肠内营养在重症急性胰腺炎治疗中的应用[J].广东医学，2015，55（3）：464-466.
[12] Wu CY，Wang HC，Wang KT，et al. Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin [J]. Biologicals，2013，41（3）：154-157.
[13] 戴上康，余洽超，周逢洽，等.注射mNGF治疗危重型小儿手足口病的效果及对患儿体液免疫功能和细胞因子的影响[J].中国医学创新，2017，14（23）：141-144.
[14] 刘欢，闫新荣.酪酸梭菌活菌散联合醒脾养儿颗粒治疗小儿消化不良性腹泻的疗效观察[J].中国医院用药评价与分析，2018，18（4）：471-472，475.
[15] 李党坚，谭华润，苏高叶，等.酪酸梭菌活菌散联合利巴韦林治疗小儿轮状病毒肠炎疗效观察[J].现代中西医结合杂志，2014，23（8）：850-851.
[16] 肖力，高平明，庞立静，等.β-内啡肽在重症手足口病发病过程中的变化[J].广东医学，2016，37（2）：272-274.
[17] 杨娟，黄永坤，王美芬，等.不同类型手足口病患儿肠黏膜屏障功能测定的临床意义[J].实用儿科临床杂志，2010， 25（10）：731-732.
[18] 邵勤，刁玉巧.EV71感染手足口病患儿血清内皮素-1水平测定及其临床意义[J].中国现代医学杂志，2013，23（26）：91-93.
[19] 邹慧.血清IgM、IgG及D-LA水平联合检测在手足口病患儿病情评估中的应用价值[J].实用中西医结合临床，2017，17（6）：103-104.
[20] 孙颖慧，奚旭阳.酪酸梭菌活菌散联合利巴韦林对儿童手足口病血清炎症因子的影响[J].中国妇幼健康研究，2017，28（2）：171-172，175.
[21] 龙铮，杜晟，李节芳，等.酪酸梭菌活菌胶囊治疗抗生素相关性新生儿腹泻的效果[J].中国当代医药，2017，24（5）：131-133.
[22] 张少辉，李宝静，王志华，等.酪酸梭菌活菌散联合醒脾养儿颗粒治疗小儿消化不良性腹泻的效果观察[J].医学综述，2016，22（12）：2425-2428.
[23] 赵炜琨，黄桂华.酪酸梭菌活菌散剂配合蓝光治疗新生儿高胆红素血症的效果[J].中国当代医药，2018，25（29）：79-81.
2019, Vol. 16 
京公网安备 11010502046598号